CTI BIOPHARMA CORP Quarterly Nonoperating Income (Expense) in USD from Q2 2010 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Cti Biopharma Corp quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2010 to Q1 2023.
  • Cti Biopharma Corp Nonoperating Income (Expense) for the quarter ending March 31, 2023 was -$4.19M, a 102% decline year-over-year.
  • Cti Biopharma Corp Nonoperating Income (Expense) for the twelve months ending March 31, 2023 was -$15.3M, a 244% decline year-over-year.
  • Cti Biopharma Corp annual Nonoperating Income (Expense) for 2022 was -$13.2M, a 412% decline from 2021.
  • Cti Biopharma Corp annual Nonoperating Income (Expense) for 2021 was -$2.58M, a 45% increase from 2020.
  • Cti Biopharma Corp annual Nonoperating Income (Expense) for 2020 was -$4.68M, a 781% decline from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$15.3M -$4.19M -$2.12M -102% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$13.2M -$3.86M -$2.45M -173% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-06
Q3 2022 -$10.7M -$3.49M -$2.69M -337% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-07
Q2 2022 -$8.06M -$3.77M -$3.6M -2131% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-08
Q1 2022 -$4.46M -$2.08M -$1.88M -959% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$2.58M -$1.41M -$1.21M -586% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-06
Q3 2021 -$1.37M -$798K -$581K -268% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$788K -$169K +$3.84M +95.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$4.62M -$196K +$59K +23.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$4.68M -$206K -$1.49M -116% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$3.19M -$217K +$118K +35.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$3.31M -$4M -$4.02M -23653% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $715K -$255K +$27K +9.57% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $688K $1.29M +$651K +102% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-17
Q3 2019 $37K -$335K -$287K -598% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $324K $17K -$2.64M -99.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $2.96M -$282K -$583K -194% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 $3.55M $637K +$1.2M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-13
Q3 2018 $2.34M -$48K +$184K +79.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-04
Q2 2018 $2.16M $2.66M +$2.56M +2505% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 -$396K $301K +$916K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 -$1.31M -$567K +$436K +43.5% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-13
Q3 2017 -$1.75M -$232K +$465K +66.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 -$2.21M $102K +$1.06M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 -$3.27M -$615K +$521K +45.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q4 2016 -$3.79M -$1M -$1.19M -636% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-07
Q3 2016 -$2.6M -$697K +$446K +39% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 -$3.05M -$955K +$784K +45.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-04
Q1 2016 -$3.83M -$1.14M +$266K +19% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 -$4.1M $187K +$2.73M Oct 1, 2015 Dec 31, 2015 10-K 2018-03-07
Q3 2015 -$6.82M -$1.14M +$1.97M +63.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 -$8.79M -$1.74M -$928K -114% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 -$7.87M -$1.4M +$131K +8.55% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$8M -$2.54M -$2.18M -600% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-02
Q3 2014 -$5.82M -$3.11M -$2.91M -1464% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 -$2.91M -$811K -$443K -120% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 -$2.46M -$1.53M -$439K -40.1% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 -$2.02M -$363K -$499K -367% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-17
Q3 2013 -$1.53M -$199K -$102K -105% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-31
Q2 2013 -$1.42M -$368K +$430K +53.9% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-04
Q1 2013 -$1.85M -$1.09M -$1.66M -292% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-29
Q4 2012 -$190K $136K -$728K -84.3% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-12
Q3 2012 $538K -$97K +$1.34M +93.3% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-30
Q2 2012 -$802K -$798K -$676K -554% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-31
Q1 2012 -$126K $569K +$303K +114% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-02
Q4 2011 -$429K $864K Oct 1, 2011 Dec 31, 2011 10-K 2014-03-04
Q3 2011 -$1.44M -$1.86M -437% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-01
Q2 2011 -$122K +$3.73M +96.8% Apr 1, 2011 Jun 30, 2011 10-Q 2011-07-28
Q1 2011 $266K Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-20
Q3 2010 $426K Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-25
Q2 2010 -$3.85M Apr 1, 2010 Jun 30, 2010 10-Q 2011-07-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.